Metoprolol Succinate
Product Images NDC 53002-2781

7 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 53002-2781). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
The image shows a rectangular white and blue blister pack of metoprolol succinate extended-release tablets. The pack is labeled with the proprietary name metoprolol succinate and displays the strength 50 mg. Each tablet is oval-shaped and white in color with a score line. The pack contains 30 tablets and the labeler is RPK Pharmaceuticals, Inc.*
FDA Label Image

1 (Image 2)

1 (Image 2)
The image shows a white and green carton box of metoprolol succinate extended-release tablets by RPK Pharmaceuticals, Inc. The front panel displays the proprietary name metoprolol succinate along with the strength of 50 mg and dosage form as extended-release tablets. The package size is 30 tablets. The product NDC 53002-2781 is also visible on the label.*
FDA Label Image

1 (Image 3)

1 (Image 3)
FDA Label Image

1 (Image 4)

1 (Image 4)
metoprolol succinate extended-release tablets by RPK Pharmaceuticals, Inc. The white bottle label prominently displays the product name, with strength indicated as 50 mg and the form noted as tablets. The label includes the product NDC 53002-2781, with clear instructions and warnings on one side. The packaging is professional and designed for medical dispensing.*
FDA Label Image

2 (Image 5)

2 (Image 5)
Chemical structure of metoprolol succinate, showing the molecular components including hydroxyl, methoxy, and amine groups, as well as the succinate moiety.*
FDA Label Image

1 (Image 6)

1 (Image 6)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality hospitalization for heart failure across various subgroups. The subgroups include geographical region, NYHA class, ejection fraction, etiology, sex, race, medical history, diabetes status, hypertension, and heart rate. The chart compares favorability between Metoprolol Succinate Extended-Release and placebo.*
FDA Label Image

Label Image (Lbl530022781)

Label Image (Lbl530022781)
The packaging label for Metoprolol Succinate 25 mg extended-release tablets, manufactured by RPK Pharmaceuticals, Inc. The label indicates the product name, strength, dosage form as oral tablets, quantity of 30 tablets, and includes directions to take one tablet daily with a meal or as directed. Additional label information includes lot number, expiration date, and barcode, with space for patient and clinic details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.